Skip to content

Effect of Repositioning Frequency Neonates Receiving Phototherapy

Effect of Repositioning Frequency on Bilirubin Level and Infant Comfort in Neonates Receiving Phototherapy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05692648
Enrollment
60
Registered
2023-01-20
Start date
2020-02-01
Completion date
2020-09-30
Last updated
2023-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bilirubinemia, Newborn Jaundice

Keywords

bilirubin, comfort, neonates, phototherapy, positioning

Brief summary

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort. Design and methods: This was a single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial conducted in a neonatal intensive care unit. Participants were randomly assigned to one of three groups: Supine position group (n = 20), hourly position change group (n = 20), and control group (n = 20). The bilirubin level and comfort levels of the neonates were evaluated.

Detailed description

Purpose: The present study was conducted to determine the effect of repositioning frequency during phototherapy on bilirubin level and neonates comfort.

Interventions

These neonates were placed in supine position, fed every 2 hours in accordance with routine clinical practice, and then returned to supine position.

BEHAVIORALHourly position change group

Infants in this group were repositioned every hour based on the time of phototherapy initiation. Neonates were initially placed in supine position and then changed to the prone position. Infants were alternated between supine and prone positions every hour for 24 hours.

BEHAVIORALControl Group (2-hour position change)

Neonates in this group were repositioned every 2 hours as routine practice based on the time of phototherapy initiation. Phototherapy was started with neonates in supine position. In the second period, the neonate was placed in the prone position after routine feeding was performed.

Sponsors

Selcuk University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Masking description

single (participant, outcomes assessor)

Intervention model description

single-centered, single-blind, 3-arm, pretest-posttest parallel-group randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
35 Weeks to 42 Weeks
Healthy volunteers
Yes

Inclusion criteria

* gestational age between 35-42 weeks * birth weight of 2000 g or more * indication for phototherapy * no previous phototherapy, * no medical diagnosis other than prenatal hyperbilirubinemia * stable health status * no clinical signs of dehydration * transition to oral feeding, no sucking problems * being at least 2 days old on the day of phototherapy

Exclusion criteria

* a sudden change in stability during phototherapy and * phototherapy duration of less than 24 hours

Design outcomes

Primary

MeasureTime frameDescription
Change in bilirubin levelBaseline and 24 hours after phototherapybilirubin level change
comfort level questionnaireup to 24 hourscomfort level change

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026